Skip to Content
Gift of Knowledge - 25% off eBooksGift of Knowledge - 25% off eBooks

Rang & Dale's Pharmacology E-Book, 10th Edition

Author :
By James M. Ritter, DPhil FRCP FBPhS FMedSci, Rod J. Flower, PhD DSc FBPhS FMedSci FRS, Graeme Henderson, BSc PhD FBPhS FSB, Yoon Kong Loke, MB, BS, MRCP, MD, David MacEwan, PhD, FRSB, FBPhS, SFHEA, Emma Robinson, PhD, FBPhS and James Fullerton, MA, MBChB, MRCP, PhD, FHEA.
PREVIOUS EDITION -ISBN : 9780702074462
Rang and Dale’s Pharmacology is internationally acknowledged as the core textbook for students of pharmacology, and has provided accessible, up-to-date information on drugs and their mechanism of action for more than 30 years. Now in its tenth e ...view more

Rang and Dale’s Pharmacology is internationally acknowledged as the core textbook for students of pharmacology, and has provided accessible, up-to-date information on drugs and their mechanism of action for more than 30 years.

Now in its tenth edition, it has been updated to include important new drugs such as gene therapies, personalised medicines and the new wave of RNA drugs. However it has not lost any of the elements that have contributed to its popularity, such as color coding and illustrations, making it reader-friendly while comprehensively covering the depth of detail required.

This essential book is recommended as the first-choice undergraduate text for science and medical students and junior doctors and will also be useful for students in other professional disciplines such as pharmacy, veterinary medicine and nursing.

ISBN :
9780323873987
Publication Date :
13-05-2023
Add to Cart

Rang and Dale’s Pharmacology is internationally acknowledged as the core textbook for students of pharmacology, and has provided accessible, up-to-date information on drugs and their mechanism of action for more than 30 years.

Now in its tenth edition, it has been updated to include important new drugs such as gene therapies, personalised medicines and the new wave of RNA drugs. However it has not lost any of the elements that have contributed to its popularity, such as color coding and illustrations, making it reader-friendly while comprehensively covering the depth of detail required.

This essential book is recommended as the first-choice undergraduate text for science and medical students and junior doctors and will also be useful for students in other professional disciplines such as pharmacy, veterinary medicine and nursing.


New to this edition
  • New chapters on drugs and the eye and the pharmacological management of headache
  • Revised information on biopharmaceuticals (including RNA drugs), antivirals (including Covid-19 therapies) as well as general principles of antimicrobial therapy.
  • A completely revised and updated chapter on lifestyle drugs
  • Recent advances in oxygen sensing and response to reduced oxygen tension
  • Expanded chapters on dementia and analgesic drugs

Key Features
  • Comprehensive information on drug mechanisms, basic physiology and biochemistry, and underlying pathophysiology of disease – suitable for students from many disciplines
  • Clear figures to aid understanding, including data figures as well as mechanistic diagrams,
  • Key points box summaries, clinical boxes and colour-coded chapters help to master difficult concepts
  • Emphasis on therapeutic drugs to help apply theory to practice
  • Over 150 questions and 12 clinical cases to test your knowledge

Author Information
By James M. Ritter, DPhil FRCP FBPhS FMedSci, Emeritus Professor of Clinical Pharmacology, King’s College London, and Medical Research Director, Quintiles, London, UK; Rod J. Flower, PhD DSc FBPhS FMedSci FRS, Professor, Biochemical Pharmacology, The William Harvey Research Institute, Barts and the London School of Medicine and Dentistry, Queen Mary University of London , London, UK; Graeme Henderson, BSc PhD FBPhS FSB, Professor of Pharmacology, University of Bristol, Bristol, UK; Yoon Kong Loke, MB, BS, MRCP, MD, Senior Lecturer in Clinical Pharmacology, School of Medicine, Health Policy and Practice, University of East Anglia, Norwich, UK; David MacEwan, PhD, FRSB, FBPhS, SFHEA, Professor of Molecular Pharmacology/Toxicology & Head of Department, Department of Molecular and Clinical Pharmacology, University of Liverpool, Liverpool, United Kingdom; Emma Robinson, PhD, FBPhS, Professor of Psychopharmacology, University of Bristol, Bristol, UK and James Fullerton, MA, MBChB, MRCP, PhD, FHEA., Associate Professor of Clinical Therapeutics and Honorary Consultant in Acute General Medicine and Clinical Pharmacology, University of Oxford, Oxford, United Kingdom